
If you own a manufacturing business, generic valuation advice only gets you so far. Most of what circulates about selling a business — clean up your books, reduce owner dependency, diversify your customers — applies to you. But manufacturing adds a set of value drivers and value destroyers that don't appear in a services business, a distribution company, or a retail operation. And in Atlantic Canada, where skilled trades shortages are acute and equipment cycles run long, some of these factors carry more weight than they do in other regions.
This article walks through the seven factors that most directly affect what a buyer will pay for a manufacturing business — and more importantly, what you can actually do about them before going to market.
Of all the factors on this list, key-person risk is the one most likely to drive a buyer to walk away or compress your multiple significantly. In Atlantic Canada, this factor carries unusual weight. Skilled trades shortages across the region mean that an experienced machinist, welder, CNC operator, or production lead represents a resource that cannot be easily replaced. Buyers know this. They will ask about your workforce — and your reliance on you personally — in one of their first conversations, and they will dig into it during due diligence.
Owner-manager dependency is the most common and costly form of key-person risk. If key customer relationships flow through you personally, if production decisions wait for your sign-off, if the business slows when you're away — buyers are not acquiring an independent business. They are acquiring a dependency, and they will price it accordingly. Discounts of 30–50% on comparable businesses are not unusual when the owner is deeply embedded with no replacement in place.
What buyers want to see:
Stay bonuses and phantom equity arrangements for key employees are increasingly common in manufacturing transactions. The structure is simple: key employees are offered a cash bonus triggered by their continued employment through the closing date and typically for a period thereafter. This aligns their interest with a successful transaction and gives buyers comfort that the knowledge and relationships embedded in your workforce will survive the sale.
For most manufacturing businesses, equipment is the single largest asset on the balance sheet. Buyers know this, and they will scrutinize it carefully. What they're looking for is not just what you have, but what state it's in and how much it will cost them to keep or replace it.
Deferred capital expenditure is one of the most common — and most costly — value destroyers in manufacturing transactions. A machine that has been fully depreciated on your books but still runs fine is not a problem. A machine that is ten years past its productive life, that requires ongoing maintenance costs and is one breakdown away from a three-week shutdown, is a problem — and buyers' accountants are trained to find it.
When a buyer discovers deferred capex, the response is typically one of three things: a dollar-for-dollar reduction in the purchase price, a holdback from closing proceeds to cover anticipated replacement costs, or a walk-away. None of these are outcomes you want. The alternative is to invest in your equipment in the years before a sale, run the capex through your P&L, normalize it as an add-back if it's genuinely one-time, or at minimum document it honestly so it's not a discovery during due diligence.
Practical actions:
Manufacturing businesses are particularly prone to customer concentration risk. Many manufacturers built their operations around a single anchor customer, and that relationship has been the foundation of growth for decades. It worked. And it may continue to work. But from a buyer's perspective, a business where 40–60% of revenue flows through one relationship is not a business — it's a dependency.
The arithmetic is straightforward. If your top customer represents half your revenue, and that customer doesn't renew their supply relationship with the new owner, the buyer has acquired a business worth half of what they paid. That risk gets priced into the multiple, often aggressively. Buyers apply a concentration discount that reflects the probability and impact of losing that relationship.
Contracted relationships with renewal provisions, long-term supply agreements, and relationships that are with the business rather than with you personally all mitigate this risk. A purchase order relationship that exists because of your personal relationship with the purchasing manager at your top customer is far more fragile — in a buyer's eyes — than a five-year supply agreement with automatic renewal provisions.
If concentration is your reality, the two- to three-year pre-sale window is the time to actively pursue customer diversification. New accounts that appear in your financial statements over two or three consecutive years provide evidence that the concentration is genuinely improving, not cosmetic.
Many manufacturers have created genuine competitive advantages that live nowhere in their formal records. A proprietary formulation developed over decades of production. Custom tooling designed in-house. A process for achieving tolerances that competitors can't match. A quality control method that reduces scrap rates to a fraction of industry averages. These are real assets — often the most valuable things in the business — and they are invisible to a buyer who can't find them in the documentation.
Formalizing IP is a pre-sale activity with high return on investment. Trademark registration for your brand and any product marks through CIPO is a filing that any experienced buyer will check — and a registration that isn't there is a gap they will note. Patent filings for genuinely novel processes or products, while not always appropriate, signal to buyers that you've taken your innovations seriously. Trade secret documentation — a formal record of what your proprietary processes are, what makes them valuable, and what protections you've put in place — turns informal competitive advantages into transferable assets.
Employment agreements that include IP assignment clauses are equally important. If your machinists and engineers have developed processes on company time using company equipment, those processes belong to the company — but only if your employment agreements say so. Buyers will check.
A manufacturing business that depends on a single supplier for a critical input is carrying a risk that most owners accept as part of doing business but that buyers will price as a liability. The 2020–2022 period made supply chain fragility visible in ways it hadn't been before. Buyers have not forgotten, and supply chain due diligence has become more rigorous as a result.
What buyers scrutinize:
This factor is categorically different from the others on this list. While most value destroyers are matters of degree — more or less customer concentration, better or worse equipment condition — environmental non-compliance can stop a transaction entirely. It is the single most common deal-killer in manufacturing M&A, and it almost always comes as a surprise to the seller.
The issue is not that manufacturing businesses are inherently dirty or non-compliant. Most are not. The issue is that manufacturing operations generate environmental exposure — in the soil, in the drainage, in the storage of materials — that accumulates over time, sometimes without anyone knowing it. A Phase I Environmental Site Assessment, which reviews historical records and identifies potential contamination risks without physical sampling, is a standard due diligence item for any manufacturing acquisition. When a Phase I identifies concerns, buyers commission a Phase II — physical testing of soil and groundwater. When a Phase II finds contamination, the transaction stalls or collapses.
The seller's protection is to know before the buyer does. Commissioning a voluntary Phase I assessment 18–24 months before going to market gives you time to understand your exposure, address remediable issues, and disclose what you know in a controlled way — rather than having a buyer discover it and weaponize it in negotiations.
Beyond environmental assessment, regulatory compliance review covers the licensing, permits, and operational certificates that the business holds and that a buyer needs to continue operating. Not every permit transfers automatically on a change of control. Understanding which ones require notice, consent, or re-application before closing is essential to keeping a deal on track.
Many manufacturing businesses own the facility they operate from. This is both an asset and a complication when it comes time to sell. The complication is structural: buyers acquiring a manufacturing business are typically paying for the operating business — the earnings, the customers, the workforce, the processes. They may or may not want to acquire the real estate as well, and the price they're willing to pay for the two things bundled together is often less than their combined value sold separately.
The principle that most experienced M&A advisors apply: separate the real estate from the operating business before the sale. Move the property to a holding company or to your personal ownership, and establish a market-rate lease between the property owner and the operating company. The buyer acquires the operating business; you retain the property and a lease income stream. The total economics of this structure are almost always superior to bundling everything together.
There are timing considerations. Transferring property between related parties triggers land transfer tax and potentially capital gains, so this restructuring needs to happen early enough that the costs are absorbed and the structure has time to settle before buyers examine it. Two to three years before a sale is the appropriate window. Attempting this within six months of going to market is both more expensive and more likely to attract CRA scrutiny.
For manufacturing businesses in Atlantic Canada, where owned industrial real estate has appreciated significantly in many communities, separating the real estate from the operating business is one of the highest-value pre-sale moves available. It deserves serious attention from your accountant and your M&A advisor well before the sale process begins.
The thread running through all seven factors on this list is that they are, to varying degrees, within your control. Equipment condition can be improved. Customer concentration can be addressed. Workforce depth can be built. IP can be formalized. Supply chain can be contracted. Environmental exposure can be identified and managed. Real estate can be separated.
None of these actions happen overnight. They require time — typically two to three years of consistent work before the improvements show up in your financials and your operations in ways that buyers will credit. Which is precisely why starting early — before you're thinking seriously about a sale, before you've picked a target date — produces better outcomes than scrambling to address these factors in the twelve months before you list.
Key-person risk sits at the top of this list for a reason — it is the factor buyers scrutinize first and that most often determines whether they proceed at confidence or with hesitation. A manufacturing business that scores well on five of seven of these factors will command a meaningfully higher multiple than one that scores well on two. The gap translates directly into dollars. For a business generating $1 million in EBITDA, the difference between a 3.5× and a 5× multiple is $1.5 million in sale price. That is a return worth working for.
Want to understand where your manufacturing business stands on these seven factors? Book a confidential assessment with Conexus M&A. We specialize in the Atlantic Canadian manufacturing market and can give you a realistic picture of where you stand and what it would take to improve it.